Ligand receives US$ 2 mn milestone payments from Merck for research pact

Ligand receives US$ 2 mn milestone payments from Merck for research pact
pharmabiz.com - 16 minutes ago
Ligand Pharmaceuticals Incorporated has received US$ 2 million in milestone payments from NV Organon, a subsidiary of Merck & Co, Inc, stemming from its research collaboration that is due to ...